Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua Living Beyond a Diagnosis Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer. by Judy Pearson Q&A Ethics in Practice Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist. by Marci A. Landsmann Policy Matters Cancer Scientists Support COVID-19 Response Researchers study ways to improve telehealth capabilities, clinical trials and health disparities. by Trevan Locke, PhD Physicians Underestimate Severity of Radiation Side Effects Breast cancer patients’ symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age. by Marci A. Landsmann Taking Drug Dosing Off Autopilot Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life. by Marcus A. Banks Reasons to Hope During the COVID-19 Pandemic Patient advocates learned about COVID-19 and cancer in an AACR virtual forum. by Kevin McLaughlin From the Editor-in-Chief Cancer in Minority Populations Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all. by William G. Nelson, MD, PhD Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel next Cancer Talk Survival Statistics 101 Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean. by Ashley P. Taylor Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus. by Marcus A. Banks Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua More Posts